Radiopharmaceuticals market are the group of pharmaceuticals drug that have radioactivity. They are used as diagnostic and therapeutic agent. Radiopharmaceuticals are exclusive medicinal formulations containing radioisotopes and are used in major clinical area for diagnosis or therapy. 

The rise in incidence and prevalence of target conditions is amongst the significant factors expected to fuel the growth and demand of radiopharmaceuticals market. In addition, the alpha radio immunotherapy-based targeted cancer treatment and the rise in initiatives to reduce the demand-supply gap of mo-99 are also anticipated to push the growth in the global radiopharmaceuticals market over the forecast period of 2021 to 2028. Likewise, the increase in application of radioisotopes in the healthcare industry and rapid surge in use of radiopharmaceuticals for the diagnosis and treatment of chronic disease are also projected to lift the growth of the market. Furthermore, the rapid technological advancements in the diagnostics sector is also expected to act as significant factors which will flourish the growth of the radiopharmaceuticals market.

The rise in use of radiopharmaceuticals in neurological applications, rapid increase in research and development for effective and lesser side effects therapies and presence of favorable regulatory scenario are expected to offer significant growth opportunities for the radiopharmaceuticals market in the forecast period of 2021 to 2028.

The radiopharmaceuticals market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 14.28 billion by 2028 and is expected to grow at a CAGR of 9.80% in the above mentioned forecast period.

This Radiopharmaceuticals Market research report intensely analyses the potential of the market with respect to current scenario and the future prospects by considering several industry aspects of Cardinal Health industry. The report also recognizes and analyses the rising trends along with major drivers, challenges and opportunities in the market. This Radiopharmaceuticals Market report provides major statistics on the market status of global and regional manufacturers and is a helpful source of assistance and direction for companies and individuals interested in Healthcare industry. The company profiles of all the chief and dominating market players and brands who are taking steps such as product launches, joint ventures, mergers and acquisitions are mentioned in the report.

Market Drivers and Restraints:

The application segment of the radiopharmaceuticals market is segmented into diagnostic applications and therapeutic applications. Diagnostic applications have further been segmented into SPECT applications and PET applications. SPECT applications have further been sub-segmented into cardiology, bone scans, thyroid applications, pulmonary scans and other SPECT applications. PET applications have further been sub-segmented into oncology, cardiology, neurology and other PET applications. Therapeutic applications have further been segmented into thyroid indications, bone metastasis, lymphoma, endocrine tumors and other indications.

Based on procedural volume assessment, the radiopharmaceuticals market is segmented into diagnostic procedures and therapeutic procedures. Diagnostic procedures have further been segmented into SPECT procedures and PET procedures. Therapeutic procedures have further been segmented into beta emitter procedures, alpha emitter procedures and brachytherapy procedures.

On the basis of source, the radiopharmaceuticals market is segmented into nuclear reactors and cyclotrons.

On the basis of end user, the radiopharmaceuticals market is segmented into hospitals, ambulatory surgical centers, diagnostic centers, cancer research institutes and others.

The major players covered in the Radiopharmaceuticals Market

The major players covered in the radiopharmaceuticals market report are Cardinal Health, Curium, GENERAL ELECTRIC COMPANY, Lantheus Medical Imaging, Inc., Bayer AG, Bracco Diagnostic Inc., Eczacibasi Monrol, Nordion (Canada) Inc.,  Advanced Accelerator Applications, NTP, Mallinckrodt., Eli Lilly and Company, Jubilant Pharma Limited, Actinium Pharmaceuticals, Inc., Merck & Co., Inc., Navidea Biopharmaceuticals, Inc., Eckert & Ziegler., Siemens Healthcare Private Limited, Novartis AG, and Beijing International Pharmaceutical Technology Co., Ltd., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Major TOC Of The Report Global Radiopharmaceuticals Market

Chapter One: Radiopharmaceuticals Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three : Global Radiopharmaceuticals MarketCompetition, by Players

Chapter Four: Global Radiopharmaceuticals Market Size by Regions

Chapter Five: Radiopharmaceuticals Market Revenue by Countries

Chapter Six: Radiopharmaceuticals Market Revenue by Countries

Chapter Seven: Radiopharmaceuticals Market Revenue by Countries

Chapter Eight: Radiopharmaceuticals Market Revenue by Countries

Key Report Highlights

Comprehensive pricing analysis based on different product types and regional segments

Market size data in terms of revenue and sales volume

Deep insights about regulatory and investment scenarios of the Radiopharmaceuticals Market   

Analysis of market effect factors and their impact on the forecast and outlook of the Radiopharmaceuticals Market   

The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the Radiopharmaceuticals Market   

A roadmap of growth opportunities available in the Radiopharmaceuticals Market   with the identification of key factors

The exhaustive analysis of various trends of the Radiopharmaceuticals Market   to help identify market developments

Key Questions Answered in Report:

What is the key to the Radiopharmaceuticals Market?

What will the Radiopharmaceuticals Market Demand and what will be Growth?

What are the latest opportunities for Radiopharmaceuticals Market in the future?

What are the strengths of the key players?

Browse Related Reports@

Ophthalmic Perimeters Market
Personalized 3D Printed Orthopedic Implants Market
Near Infrared Imaging Market
About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]